Evidence map›Paper›PMID 30354048›Full record

ArticleACS infectious diseases2018

Role of a Small Molecule in the Modulation of Cell Death Signal Transduction Pathways.

Stella Hartmann, David J Nusbaum, Kevin Kim, Saleem Alameh, Chi-Lee C Ho, Renae L Cruz, Anastasia Levitin, Kenneth A Bradley, Mikhail Martchenko

Abstract read
In one paragraph

Article in ACS infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  4. Article
  5. Cardioprotective Effect of (Cardiovascular therapeutics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Stella HartmannSchool of Applied Life Sciences , Keck Graduate Institute , 535 Watson Drive , Claremont , California 91711 , United States.
David J NusbaumDepartment of Microbiology, Immunology and Molecular Genetics , University of California, Los Angeles , 609 Charles E. Young Drive East , Los Angeles , California 90095 , United States.
Kevin KimSchool of Applied Life Sciences , Keck Graduate Institute , 535 Watson Drive , Claremont , California 91711 , United States.
Saleem AlamehSchool of Applied Life Sciences , Keck Graduate Institute , 535 Watson Drive , Claremont , California 91711 , United States.
Chi-Lee C HoDepartment of Microbiology, Immunology and Molecular Genetics , University of California, Los Angeles , 609 Charles E. Young Drive East , Los Angeles , California 90095 , United States.
Renae L CruzDepartment of Microbiology, Immunology and Molecular Genetics , University of California, Los Angeles , 609 Charles E. Young Drive East , Los Angeles , California 90095 , United States.
Anastasia LevitinSchool of Applied Life Sciences , Keck Graduate Institute , 535 Watson Drive , Claremont , California 91711 , United States.
Kenneth A BradleyDepartment of Microbiology, Immunology and Molecular Genetics , University of California, Los Angeles , 609 Charles E. Young Drive East , Los Angeles , California 90095 , United States.
Mikhail MartchenkoSchool of Applied Life Sciences , Keck Graduate Institute , 535 Watson Drive , Claremont , California 91711 , United States.ORCID 0000-0003-2577-2915
Keck Graduate Institute · USUniversity of California, Los Angeles · US

Funding

UCLA MSD ProgramR25GM055052 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BARBER, PAUL HENRY, HASSON, TAMA W. · 1996 to 2021
$9.2M
NIGMS NIH HHS R25 GM055052
6 · The paper itself

Abstract

Inflammasomes activate caspase-1 in response to molecular signals from pathogens and other dangerous stimuli as a part of the innate immune response. A previous study discovered a small-molecule, 4-fluoro- N'-[1-(2-pyridinyl)ethylidene]benzohydrazide, which we named DN1, that reduces the cytotoxicity of anthrax lethal toxin (LT). We determined that DN1 protected cells irrespectively of LT concentration and reduced the pathogenicity of an additional bacterial exotoxin and several viruses. Using the LT cytotoxicity pathway, we show that DN1 does not prevent LT internalization and catalytic activity or caspase-1 activation. Moreover, DN1 does not affect the proteolytic activity of host cathepsin B, which facilitates the cytoplasmic entry of toxins. PubChem Bioactivities lists two G protein-coupled receptors (GPCR), type-1 angiotensin II receptor and apelin receptor, as targets of DN1. The inhibition of phosphatidylinositol 3-kinase, phospholipase C, and protein kinase B, which are downstream of GPCR signaling, synergized with DN1 in protecting cells from LT. We hypothesize that DN1-mediated antagonism of GPCRs modulates signal transduction pathways to induce a cellular state that reduces LT-induced pyroptosis downstream of caspase-1 activation. DN1 also reduced the susceptibility of Drosophila melanogaster to toxin-associated bacterial infections. Future experiments will aim to further characterize how DN1 modulates signal transduction pathways to inhibit pyroptotic cell death in LT-sensitive macrophages. DN1 represents a novel chemical probe to investigate host cellular mechanisms that mediate cell death in response to pathogenic agents.

Indexed as

AnimalsAnthraxAnti-Bacterial AgentsAntigens, BacterialBacillus anthracisBacterial ToxinsCaspase 1Cathepsin BCell DeathDrosophila melanogasterFemaleHost-Pathogen InteractionsHumansMacrophagesMiceRAW 264.7 Cellsanthrax toxinAnti-Bacterial AgentsAntigens, BacterialBacterial ToxinsCaspase 1Cathepsin BSmall Molecule Librariesanthrax toxinbroad-spectrumdrug discoveryG protein-coupled receptorhost-orientedpyroptosis

Identifiers

PMID30354048
PMCPMC6467792
OpenAlexW2898506883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.